Activation of Factor XII-dependent Pathways in Human Plasma by Hematin and Protoporphyrin

Overview

Journal J Clin Invest

Specialty General Medicine

Date 1985 Aug 1

PMID 4031058

Citations 4

Authors

C G Becker

M Wagner

A P Kaplan

M Silverberg

R W Grady

H Liem

U Muller-Eberhard

Affiliations

Soon will be listed here.

Abstract

Intravenous administration of hematin is effective in the treatment of acute exacerbations of the inducible porphyrias. In the course of such treatment, coagulopathies have occurred that are characterized by prolongation of prothrombin time, partial thromboplastin time, and formation of fibrin split products. In experiments in vitro with normal human plasma, we observed that hematin and protoporphyrin activated Factor XII-dependent pathways of coagulation and fibrinolysis, and that they generated kallikrein activity. Incubation of protoporphyrin with purified Factor XII resulted in activation as measured by amidolysis of a chromogenic substrate. Neither coproporphyrin, uroporphyrin, delta-aminolevulinic acid, porphobilinogen, or bilirubin activated Factor XII-dependent pathways. Exposure of serum containing added uroporphyrin, coproporphyrin, and protoporphyrin, but not hematin, to ultraviolet light (405 nm) resulted in activation of the classical pathway of the complement system. On the other hand, exposure of plasma containing uroporphyrin or coproporphyrin to ultraviolet light did not result in activation of Factor XII-dependent pathways.

Citing Articles

Oxidized hemoglobin triggers polyreactivity and autoreactivity of human IgG via transfer of heme.

Planchais C, Noe R, Gilbert M, Lecerf M, Kaveri S, Lacroix-Desmazes S Commun Biol. 2023; 6(1):168.

PMID: 36774392 PMC: 9922299. DOI: 10.1038/s42003-023-04535-5.

Exploring the Complex Network of Heme-Triggered Effects on the Blood Coagulation System.

Mubeen S, Domingo-Fernandez D, Diaz Del Ser S, Solanki D, Kodamullil A, Hofmann-Apitius M J Clin Med. 2022; 11(19).

PMID: 36233841 PMC: 9572022. DOI: 10.3390/jcm11195975.

Linking Labile Heme with Thrombosis.

Hopp M, Imhof D J Clin Med. 2021; 10(3).

PMID: 33499296 PMC: 7865584. DOI: 10.3390/jcm10030427.

Upregulation of prolylcarboxypeptidase (PRCP) in lipopolysaccharide (LPS) treated endothelium promotes inflammation.

Ngo M, Mahdi F, Kolte D, Shariat-Madar Z J Inflamm (Lond). 2009; 6:3.

PMID: 19171072 PMC: 2639534. DOI: 10.1186/1476-9255-6-3.

References

Ogston D, BENNETT N, OGSTON C, Ratnoff O . The assay of a plasma component necessary for the generation of a plasminogen activator in the presence of Hageman factor (Hageman factor co-factor). Br J Haematol. 1971; 20(2):209-16. DOI: 10.1111/j.1365-2141.1971.tb07029.x. View

LAURELL C . ANTIGEN-ANTIBODY CROSSED ELECTROPHORESIS. Anal Biochem. 1965; 10:358-61. DOI: 10.1016/0003-2697(65)90278-2. View

Seery V, Morgan W, Muller-Eberhard U . Interaction of rabbit hemopexin with rose bengal and photooxidation of the rose bengal-hemopexin complex. J Biol Chem. 1975; 250(16):6439-44. View

Brown S, Shillcock M, Jones P . Equilibrium and kinetic studies of the aggregation of porphyrins in aqueous solution. Biochem J. 1976; 153(2):279-85. PMC: 1172573. DOI: 10.1042/bj1530279. View

Becker C, Dubin T . Activation of factor XII by tobacco glycoprotein. J Exp Med. 1977; 146(2):457-67. PMC: 2180772. DOI: 10.1084/jem.146.2.457. View

Griffin J . Role of surface in surface-dependent activation of Hageman factor (blood coagulation factor XII). Proc Natl Acad Sci U S A. 1978; 75(4):1998-2002. PMC: 392470. DOI: 10.1073/pnas.75.4.1998. View

Claeson G, Friberger P, Knos M, Eriksson E . Methods for determination of prekallikrein in plasma, glandular kallikrein and urokinase. Haemostasis. 1978; 7(2-3):76-8. DOI: 10.1159/000214238. View

Lamon J, Frykholm B, Hess R, TSCHUDY D . Hematin therapy for acute porphyria. Medicine (Baltimore). 1979; 58(3):252-69. DOI: 10.1097/00005792-197905000-00005. View

Collier G, PRATT J, De Wet C, Tshabalala C . Studies on haemin in dimethyl sulphoxide/water mixtures. Biochem J. 1979; 179(2):281-9. PMC: 1186625. DOI: 10.1042/bj1790281. View

10.

Miller G, Silverberg M, Kaplan A . Autoactivatability of human Hageman factor (factor XII). Biochem Biophys Res Commun. 1980; 92(3):803-10. DOI: 10.1016/0006-291x(80)90774-3. View

11.

Silverberg M, Dunn J, Garen L, Kaplan A . Autoactivation of human Hageman factor. Demonstration utilizing a synthetic substrate. J Biol Chem. 1980; 255(15):7281-6. View

12.

Gigli I, Schothorst A, Soter N, Pathak M . Erythropoietic protoporphyria. Photoactivation of the complement system. J Clin Invest. 1980; 66(3):517-22. PMC: 371680. DOI: 10.1172/JCI109883. View

13.

Lim H, Perez H, Goldstein I, Gigli I . Generation of chemotactic activity in serum from patients with erythropoietic protoporphyria and porphyria cutanea tarda. N Engl J Med. 1981; 304(4):212-6. DOI: 10.1056/NEJM198101223040406. View

14.

Lim H, Perez H, Goldstein I, Gigli I . Complement-derived chemotactic activity is generated in human serum containing uroporphyrin after irradiation with 405 nm light. J Clin Invest. 1981; 67(4):1072-7. PMC: 370666. DOI: 10.1172/jci110119. View

15.

Hojima Y, PIERCE J, Pisano J . Hageman factor fragment inhibitor in corn seeds: purification and characterization. Thromb Res. 1980; 20(2):149-62. DOI: 10.1016/0049-3848(80)90381-3. View

16.

Morris D, Dudley M, Pearson R . Coagulopathy associated with hematin treatment for acute intermittent porphyria. Ann Intern Med. 1981; 95(6):700-1. DOI: 10.7326/0003-4819-95-6-700. View

17.

Truedsson L, Sjoholm A, LAURELL A . Screening for deficiencies in the classical and alternative pathways of complement by hemolysis in gel. Acta Pathol Microbiol Scand C. 1981; 89(3):161-6. DOI: 10.1111/j.1699-0463.1981.tb02680.x. View

18.

Yamamoto T, Cochrane C . A protease-like permeability factor in guinea pig skin: immunologic identity with plasma Hageman factor. Am J Pathol. 1982; 107(2):127-34. PMC: 1916013. View

19.

Silverberg M, Kaplan A . Enzymatic activities of activated and zymogen forms of human Hageman factor (factor XII). Blood. 1982; 60(1):64-70. View

20.

Duff G, Atkins E . The inhibitory effect of polymyxin B on endotoxin-induced endogenous pyrogen production. J Immunol Methods. 1982; 52(3):333-40. DOI: 10.1016/0022-1759(82)90005-9. View